Recent Advances in Anticoagulant Treatment of Immune Thrombosis: A Focus on Direct Oral Anticoagulants in Heparin-Induced Thrombocytopenia and Anti-Phospholipid Syndrome.

Carré, Julie; Jourdi, Georges; Gendron, Nicolas; Helley, Dominique; Gaussem, Pascale; Darnige, Luc

Carré, Julie; Jourdi, Georges; Gendron, Nicolas; Helley, Dominique; Gaussem, Pascale; Darnige, Luc.

Afiliação

Carré J; Hematology Department, CHU de Poitiers, 86021 Poitiers, France.
Jourdi G; Research Center, Montreal Heart Institute, Montreal, QC H1T 1C8, Canada.
Gendron N; Faculty of Pharmacy, Université de Montréal, Montreal, QC H3T 1J4, Canada.
Helley D; Innovative Therapies in Haemostasis, INSERM UMR-S1140, University of Paris, 75006 Paris, France.
Gaussem P; Biosurgical Research Lab (Carpentier Foundation), AP-HP, 75015 Paris, France.
Darnige L; Biological Hematology Department, Assistance Publique-Hôpitaux de Paris-Centre (AP-HP.CUP), 75015 Paris, France.

Int J Mol Sci ; 23(1)2021 Dec 22.

Article em En | MEDLINE | ID: mdl-35008518

Assuntos

Anticoagulantes/uso terapêutico; Síndrome Antifosfolipídica/tratamento farmacológico; Trombocitopenia/tratamento farmacológico; Administração Oral; Humanos; Trombose/tratamento farmacológico

Palavras-chave

antiphospholipid syndrome; direct oral anticoagulants; heparin-induced thrombocytopenia; immune thrombosis; vaccine-induced immune thrombotic thrombocytopenia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombocitopenia / Síndrome Antifosfolipídica / Anticoagulantes Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google